Stock Market

Vijay Kedia’s Contrarian Bet: Unpacking the Mangalam Drugs Microcap Acquisition Amidst Steep Decline

by
vijay kedias contrarian bet unpacking the mangalam drugs microcap acquisition amidst steep decline

Ace investor Vijay Kedia, operating through Kedia Securities Private Ltd., has recently executed a significant bulk deal on the National Stock Exchange (NSE), acquiring 1.38 …

Read more

SBI Mutual Fund’s Nazara Divestment: A Strategic Rebalancing Amidst Gaming Sector Growth

by

SBI Mutual Fund recently executed a substantial divestment, selling a 2.43% stake in Nazara Technologies, India’s leading diversified gaming and sports media platform, for approximately …

Read more